Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James H Lewis

Showing results (11-20 of 99) with videos related to

Pageof 10
Sort By:
Digestive Diseases and Sciences|May 15, 2012
Clinical perspective: statins and the liver--harmful or helpful?James H Lewis
Expert Opinion on Drug Safety|August 9, 2003
The rational use of potentially hepatotoxic medications in patients with underlying liver diseaseJames H Lewis
Clinical Liver Disease|April 18, 2019
Causality assessment: Which is best-expert opinion or RUCAM?James H Lewis
Hepatology (Baltimore, Md.)|January 6, 2022
Digitizing DILI: Who can? RUCAM? RECAM?James H Lewis
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 28, 2015
The Art and Science of Diagnosing and Managing Drug-induced Liver Injury in 2015 and BeyondJames H Lewis
Nature Reviews. Gastroenterology & Hepatology|August 25, 2011
Diagnosis: Liver biopsy differentiates DILI from autoimmune hepatitisJames H Lewis
Current Opinion in Gastroenterology|February 11, 2005
Drug-induced liver diseaseDavid Novak, James H Lewis
Journal of the National Medical Association|June 26, 2010
Gone (from the Physicians' desk reference) but not forgotten: propylthiouracil-associated hepatic failure: a call for liver test monitoringJennifer Primeggia, James H Lewis
Current Opinion in Gastroenterology|April 7, 2007
Drug-induced liver disease in 2006Cherinne Arundel, James H Lewis
Expert Opinion on Drug Metabolism & Toxicology|June 10, 2009
Drug-induced liver injury: what was new in 2008?Gordon Liss, James H Lewis
Pageof 10

Showing results (11-20 of 99) with videos related to

Sort By:
Pageof 10
Digestive Diseases and Sciences|May 15, 2012
Clinical perspective: statins and the liver--harmful or helpful?James H Lewis
Expert Opinion on Drug Safety|August 9, 2003
The rational use of potentially hepatotoxic medications in patients with underlying liver diseaseJames H Lewis
Clinical Liver Disease|April 18, 2019
Causality assessment: Which is best-expert opinion or RUCAM?James H Lewis
Hepatology (Baltimore, Md.)|January 6, 2022
Digitizing DILI: Who can? RUCAM? RECAM?James H Lewis
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 28, 2015
The Art and Science of Diagnosing and Managing Drug-induced Liver Injury in 2015 and BeyondJames H Lewis
Nature Reviews. Gastroenterology & Hepatology|August 25, 2011
Diagnosis: Liver biopsy differentiates DILI from autoimmune hepatitisJames H Lewis
Current Opinion in Gastroenterology|February 11, 2005
Drug-induced liver diseaseDavid Novak, James H Lewis
Journal of the National Medical Association|June 26, 2010
Gone (from the Physicians' desk reference) but not forgotten: propylthiouracil-associated hepatic failure: a call for liver test monitoringJennifer Primeggia, James H Lewis
Current Opinion in Gastroenterology|April 7, 2007
Drug-induced liver disease in 2006Cherinne Arundel, James H Lewis
Expert Opinion on Drug Metabolism & Toxicology|June 10, 2009
Drug-induced liver injury: what was new in 2008?Gordon Liss, James H Lewis
Pageof 10